WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000061162) USE OF TETRAHYDROCURCUMINOIDS TO REGULATE PHYSIOLOGICAL AND PATHOLOGICAL EVENTS IN THE SKIN AND MUCOSA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/061162    International Application No.:    PCT/US2000/008711
Publication Date: 19.10.2000 International Filing Date: 07.04.2000
Chapter 2 Demand Filed:    09.11.2000    
IPC:
A61K 8/35 (2006.01), A61K 31/12 (2006.01), A61K 41/00 (2006.01), A61Q 19/02 (2006.01)
Applicants: SABINSA CORPORATION [US/US]; 121 Ethel Road West, Unit #6, Piscataway, NJ 08854 (US) (For All Designated States Except US).
SAMI CHEMICALS AND EXTRACTS (P) LTD. [IN/IN]; 19-1 & 19-2 1 Main, II Stage, Peenya Industrial Area, Peenya, Bangalore 560 058 (IN) (For All Designated States Except US).
MAJEED, Muhammed [US/US]; (US) (For US Only).
BADMAEV, Vladimir [US/US]; (US) (For US Only)
Inventors: MAJEED, Muhammed; (US).
BADMAEV, Vladimir; (US)
Agent: MURRAY, Robert, B.; Arent Fox Plotkin Kintner & Kahn, PLLC, Suite 600, 1050 Connecticut Avenue, N.W., Washington, DC 20036-5339 (US)
Priority Data:
60/128,540 09.04.1999 US
Title (EN) USE OF TETRAHYDROCURCUMINOIDS TO REGULATE PHYSIOLOGICAL AND PATHOLOGICAL EVENTS IN THE SKIN AND MUCOSA
(FR) UTILISATION DE TETRAHYDROCURCUMINOIDES POUR LA REGULATION D'EVENEMENTS PHYSIOLOGIQUES ET PATHOLOGIQUES AU NIVEAU DE LA PEAU ET DES MUQUEUSES
Abstract: front page image
(EN)The present invention is directed to a mixture of tetrahydrocurcuminoids which can be used for regulating random intracellular protein crosslinking, optimizing cell electric potential, treating a premalignant state or a malignancy, increasing intracellular transglutaminase activity, and reducing 'age spots' due to lipofuscin formation.
(FR)La présente invention concerne un mélange de tétrahydrocurcuminoïdes que l'on peut utiliser pour réguler la réticulation aléatoire des protéines intracellulaire, optimiser le potentiel électrique des cellules, traiter un état précancéreux ou une malignité, augmenter l'activité des transglutaminases intracellulaires, et réduire les 'taches de vieillesse' dues à la formation de lipofuscine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)